Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
163.46 USD | -0.61% |
|
+1.06% | +38.41% |
Jul. 01 | JPMorgan Adjusts Price Target on Cardinal Health to $175 From $156 | MT |
Jun. 30 | Cardinal Health, Inc.(NYSE:CAH) added to Russell 1000 Value-Defensive Index | CI |
Capitalization | 39.25B 33.52B 31.29B 28.94B 53.71B 3,367B 60.17B 375B 142B 1,571B 147B 144B 5,763B | P/E ratio 2025 * |
23.3x | P/E ratio 2026 * | 20.9x |
---|---|---|---|---|---|
Enterprise value | 41.99B 35.87B 33.48B 30.96B 57.46B 3,603B 64.37B 401B 152B 1,681B 158B 154B 6,165B | EV / Sales 2025 * |
0.19x | EV / Sales 2026 * | 0.16x |
Free-Float |
89.22% | Yield 2025 * |
1.25% | Yield 2026 * | 1.27% |
More valuation ratios
* Estimated data
More news
Last Transcript: Cardinal Health, Inc.
More recommendations
More press releases
More news
1 day | -0.93% | ||
1 week | +0.52% | ||
Current month | -3.08% | ||
1 month | +6.00% | ||
3 months | +24.82% | ||
6 months | +33.94% | ||
Current year | +37.68% |
1 week | 161 | ![]() | 168.06 |
1 month | 151.62 | ![]() | 168.44 |
Current year | 117.53 | ![]() | 168.44 |
1 year | 93.17 | ![]() | 168.44 |
3 years | 51.95 | ![]() | 168.44 |
5 years | 44.65 | ![]() | 168.44 |
10 years | 39.05 | ![]() | 168.44 |
Manager | Title | Age | Since |
---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 52 | 2022-08-31 |
Aaron Alt
DFI | Director of Finance/CFO | 54 | 2023-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 55 | 2022-07-31 |
Director | Title | Age | Since |
---|---|---|---|
Gregory Kenny
CHM | Chairman | 72 | 2018-10-31 |
Director/Board Member | 72 | 2013-09-11 | |
Nancy Killefer
BRD | Director/Board Member | 70 | 2015-09-13 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.91% | +0.52% | +69.60% | +207.28% | 39.25B | ||
-0.52% | +1.99% | +22.61% | +118.81% | 90.59B | ||
-3.34% | -3.34% | - | - | 22.52B | ||
-1.06% | -2.82% | +42.51% | -13.48% | 9.57B | ||
+0.22% | +0.78% | -5.56% | -1.15% | 8.38B | ||
-0.11% | -0.43% | -9.04% | -6.59% | 7.33B | ||
+1.11% | +0.91% | +18.53% | +15.44% | 5.48B | ||
-4.51% | -8.09% | -15.37% | -8.79% | 5.36B | ||
+0.63% | +3.25% | +23.91% | +2.14% | 4.83B | ||
+1.35% | +2.54% | +8.70% | +19.62% | 3.65B | ||
Average | -0.72% | -0.14% | +17.32% | +37.03% | 19.7B | |
Weighted average by Cap. | -0.90% | -0.29% | +30.04% | +107.95% |
2025 * | 2026 * | |
---|---|---|
Net sales | 223B 191B 178B 165B 306B 19,159B 342B 2,133B 810B 8,938B 838B 820B 32,787B | 249B 213B 199B 184B 341B 21,385B 382B 2,381B 904B 9,976B 935B 916B 36,596B |
Net income | 1.7B 1.45B 1.35B 1.25B 2.32B 146B 2.6B 16.22B 6.16B 67.96B 6.37B 6.24B 249B | 1.78B 1.52B 1.42B 1.31B 2.44B 153B 2.73B 17.03B 6.46B 71.34B 6.69B 6.55B 262B |
Net Debt | 2.74B 2.34B 2.19B 2.02B 3.76B 235B 4.21B 26.22B 9.95B 110B 10.29B 10.08B 403B | 1.23B 1.05B 981M 908M 1.68B 106B 1.89B 11.76B 4.46B 49.28B 4.62B 4.52B 181B |
More financial data
* Estimated data
Employees
48,411
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-09 | 163.66 $ | -0.48% | 672,472 |
25-07-08 | 164.45 $ | -1.90% | 2,066,913 |
25-07-07 | 167.63 $ | +1.64% | 1,910,580 |
25-07-03 | 164.93 $ | +1.82% | 1,234,057 |
25-07-02 | 161.98 $ | -1.47% | 3,129,587 |
Delayed Quote Nyse, July 09, 2025 at 10:08 am EDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
17
Last Close Price
164.45USD
Average target price
173.47USD
Spread / Average Target
+5.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions